Application 065326
- Type
- ANDA
- Sponsor
- ORCHID HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEPHALEXIN | CEPHALEXIN | FOR SUSPENSION;ORAL | EQ 125MG BASE/5ML | No | No |
| 002 | CEPHALEXIN | CEPHALEXIN | FOR SUSPENSION;ORAL | EQ 250MG BASE/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065326-001 | CEPHALEXIN | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | ||
| A065326-002 | CEPHALEXIN | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2006-07-10 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A065326-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A065326-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | 2006-07-10 | 3bdfa0b2c4d7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | A065326-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065326-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065326-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065326-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065326-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065326-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A065326-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A065326-002 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065326-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065326-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A065326-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A065326-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A065326-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A065326-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A065326-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A065326-002 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A065326-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A065326-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A065326-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A065326-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A065326-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A065326-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | 2506895d-f3e0-4be9-95cb-7a6fd44de46d | 2026-11-06 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | 9fc5cfb0-7ba0-4669-b79c-270b6a9ff573 | 2026-10-29 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 681c235f-6dee-1401-e053-2991aa0addc0 | 2026-10-28 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | c0ca008e-0e28-412e-a58f-70f63817713b | 2026-10-23 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 7cbdfa7f-2ea0-48e1-b506-59f58e5685a6 | 2026-10-19 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 73920373-b45d-45d6-b183-d962467dde36 | 2026-10-19 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Ascend Laboratories, LLC | 36882c6d-7b6f-41e3-8c54-e3b0073b8c07 | 2026-10-16 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Northwind Health Company, LLC | 4ecf9314-76e2-c270-e063-6294a90ad8db | 2026-10-16 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | 8499aa5a-49b1-4555-bd27-6177d92b261d | 2026-10-15 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | b3bb8222-161e-4d9c-8e08-7e22ad65bf72 | 2026-10-13 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | b73593ce-0b1f-4371-bae1-140742de3b42 | 2026-10-12 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Ascend Laboratories, LLC | bb28751c-bd1b-4e7f-8271-a14c1b4314e3 | 2026-10-12 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Aurobindo Pharma Limited | f957ea27-2906-40c7-ac03-eb2f742473a0 | 2026-09-15 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Aurobindo Pharma Limited | 8e28f049-6110-4473-830f-c494191a7197 | 2026-09-15 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | e54df878-c235-4aa3-af33-fe5287c73138 | 2026-09-14 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | 1716ea1e-40a9-4a23-870b-3c7e3d070095 | 2026-09-14 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 6c543819-ab98-1dcd-e053-2991aa0a109d | 2026-09-14 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Teva Pharmaceuticals USA, Inc. | 5858b90a-a80d-40b4-9275-b89e9121ea42 | 2026-09-02 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Lupin Pharmaceuticals, Inc. | 1d3e6d33-5dc2-498e-8efa-e3c4fca15dff | 2026-08-24 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | HAWAII REPACK, INC. | d54abc0a-3c8f-4f02-bd55-406f0c5b925a | 2026-08-18 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42043-142 | Cephalexin | Cephalexin | OrchidPharma Inc | ANDA | Current |
| 42043-142 | Cephalexin | Cephalexin | OrchidPharma Inc | ANDA | Current |
| 42043-143 | Cephalexin | Cephalexin | OrchidPharma Inc | ANDA | Current |
| 42043-143 | Cephalexin | Cephalexin | OrchidPharma Inc | ANDA | Current |
| 42254-338 | Cephalexin | Cephalexin | Rebel Distributors Corp | ANDA | Current |
| 50090-2552 | Cephalexin | Cephalexin | A-S Medication Solutions | ANDA | Current |
| 55700-563 | Cephalexin | Cephalexin | Lake Erie Medical DBA Quality Care Products LLC | ANDA | Current |
| 59834-202 | Cephalexin | Cephalexin | OrchidPharma Inc | ANDA | Current |
| 59834-203 | Cephalexin | Cephalexin | OrchidPharma Inc | ANDA | Current |
| 66267-981 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 66267-981 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-1585 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-1585 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4233 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4233 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68788-7391 | Cephalexin | Cephalexin | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-7391 | Cephalexin | Cephalexin | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-8986 | Cephalexin | Cephalexin | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-8986 | Cephalexin | Cephalexin | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 68788-8986 | Cephalexin | Cephalexin | Preferred Pharmaceuticals Inc. | ANDA | Current |